First Manhattan CO Puma Biotechnology, Inc. Transaction History

First Manhattan CO

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 16, 2019	SELL	$12.3 - $35.76 $5.24 Million - $15.2 Million	-425,900 Closed	0 $0
Q1 2019 Apr 12, 2019	SELL	$20.77 - $42.37 $213,931 - $436,411	-10,300 Reduced 2.36%	425,900 $16.5 Million
Q4 2018 Jan 30, 2019	BUY	$20.07 - $46.7 $8.75 Million - $20.4 Million	436,200 New	436,200 $8.88 Million

101

29M

60.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $136M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.